STOCK TITAN
  1. Home
  2. News
  3. EW

EDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON JULY 26, 2023

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary
Edwards Lifesciences (NYSE: EW) to announce Q2 2023 operating results on July 26, 2023. Conference call at 5:00 p.m. ET. Dial (877) 704-2848 or (201) 389-0893 to participate. Live and archived on ir.edwards.com.
Positive
  • None.
Negative
  • None.

IRVINE, Calif., July 19, 2023 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended June 30, 2023 after the market closes on Wednesday, July 26, 2023, and will host a conference call at 5:00 p.m. ET that day to discuss those results.

To participate in the conference call, dial (877) 704-2848 or (201) 389-0893. The call will also be available live and archived on the "Investor Relations" section of the Edwards website at ir.edwards.com.

About Edwards Lifesciences
Edwards Lifesciences, is the global leader of patient-focused innovations for structural heart disease and critical care monitoring.  We are driven by a passion for patients, dedicated to improving and enhancing lives through partnerships with clinicians and stakeholders across the global healthcare landscape. For more information, visit Edwards.com and follow us on Facebook, Instagram, LinkedIn, Twitter and YouTube.

Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation. All other trademarks are the property of their respective owners.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/edwards-lifesciences-to-host-earnings-conference-call-on-july-26-2023-301880542.html

SOURCE Edwards Lifesciences Corporation

FAQ

What is the ticker symbol for Edwards Lifesciences?

The ticker symbol for Edwards Lifesciences is EW.

When will Edwards Lifesciences announce its Q2 2023 operating results?

Edwards Lifesciences plans to announce its Q2 2023 operating results on July 26, 2023.

How can I participate in the conference call to discuss the results?

To participate in the conference call, dial (877) 704-2848 or (201) 389-0893.

Where can I find the live and archived conference call?

The conference call will be available live and archived on the 'Investor Relations' section of the Edwards website at ir.edwards.com.

Stock EW logo
Edwards Lifesciences Corp

NYSE:EW

EW Rankings

#237 Ranked by Market Cap
#3019 Ranked by Stock Gains
N/A Ranked by Dividends

EW Latest News

Apr 25, 2024
Edwards Lifesciences Reports First Quarter Results
Apr 18, 2024
Edwards Lifesciences to Host Earnings Conference Call on April 25, 2024
Apr 7, 2024
Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It
Mar 19, 2024
PECA Labs Receives Expanded CE Mark for exGraft Family of Vascular Grafts, Allowing for Expandability Designed to Match Growth or Help Avoid Restenosis
Mar 11, 2024
Large, Real-world Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVR

EW Stock Data

51.37B
595.33M
0.89%
84.02%
1.73%
Surgical Appliance and Supplies Manufacturing
Manufacturing
Link
United States of America
IRVINE

About EW

edwards lifesciences (nyse: ew) is the global leader in the science of heart valves and hemodynamic monitoring. driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that save and enhance lives. headquartered in irvine, california, edwards lifesciences has extensive operations in north america, europe, japan, latin america and asia and currently employs about 6,400 individuals worldwide. for us, helping patients is not a slogan – it's our life’s work. from developing devices that replace or repair a diseased heart valve to creating new technologies that monitor vital signs in the critical care setting, we help ensure that patients regain and even improve their quality of life.